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European Society for Therapeutic Radiology and Oncology (ESTRO), 
the European Association of Nuclear Medicine (EANM) and the 
Cardiovascular and Interventional Radiological Society of Europe 
(CIRSE). The activities of MEDRAPET have focused on three main tasks 
i.e. a) the conduction of a survey onradiation protection education 
and training of medical professionals in the EUmember states, b) the 
organization of a European workshop and c) thedevelopment of a 
European Guidance document on radiation protection educationand 
training of medical professionals.   
A European Union study was performed to obtain a view on the status 
and legal and practical arrangements in the European Member States 
regarding radiation protection education and training of medical 
professionals. A questionnaire with specific sections for radiation 
protection authorities, national professional societies and educational 
institutions was developed. For the radiation protection authorities 
section, there were 28 respondents (57.1% response rate). The 
response rate for professional societies was 25.3% (509 contacts - 129 
answers) and for educational institutions 19.8% (465 contacts – 92 
answers). Results of this survey show that there is a need for 
implementation of the medical exposure directive’s requirements on 
radiation protection education and training of medical professionals in 
many states of the European Union. Also, interventional cardiologists, 
vascular surgeons and other interventionalists have a need for 
dedicated training in radiation protection for fluoroscopically-guided 
interventional procedures. 
The results of the MEDRAPET survey were discussed during the 
MEDRAPET workshop organized in Athens, Greece from 21 to 23 of 
April, 2012. A wide audience of professionals involved in medical 
radiation protection attended the workshop (one hundred and eight 
participants from 29 different countries). Representatives of 
international organizations, professional societies, regulatory 
organizations and university students examined opportunities, 
difficulties and future trends in medical radiation protection 
education and training. Input was obtained for the drafting of the 
guidance document. The guidance document provides guidelines on 
radiation protection education and training of medical professionals in 
the European Union. The main part of the guidance document is 
focused on learning outcomes for each medical profession working 
with ionizing radiation defined interms of knowledge, skills and 
competence (KSC) in accordance with the European Qualifications 
Framework and the European Guidelines for lifelong learning.  
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As the final outcome of the MEDRAPET project, the guidance 
document shall give specific learning outcomes for each professional 
group, reflecting its need for education and training in radiation 
protection. The section on radiologists concentrates on those aspects 
where radiologists are most influential, and learning outcomes of 
education and training in radiology are presented in KSC table format, 
according to the systematic structure used for  the presentations of all 
medical professions. The contents have been coordinated with the 
Education Committee of the European Society of Radiology and will be 
reflected in the revised training charter for radiologists.  
CT alone is responsible for at least 50% of the medical exposure to the 
population in most European countries, and the risk is mostly 
stochastic. This contribution is the result of both a high number of 
examinations and a relatively elevated individual patient dose. 
Radiologists - in cooperation with the referring clinician - are 
responsible for justification; choosing the best imaging method for 
each individual medical problem, thus, has a top priority in the 
learning objectives. In addition, in CT optimisation - depending on 
the specific application - can reduce individual exposure by around 
50% to 90%. This has become possible through technical advances 
(such as automatic exposure control and iterative image 
reconstruction) but requires adequate knowledge of the different 
tools and protocol adaptation to the specific body habitus, most 
important in children and obese adults. 
Similar to CT, optimisation and justification are important for 
radiographic and fluoroscopic examinations although the 
contribution to the exposure of the population is smaller. In 
fluoroscopy, two additional aspects have to be covered by the 
learning objectives: deterministic effects (mainly to the skin) and 
occupational exposure of the personnel are therefore included in the 
education. 
Interventional radiology is different from general radiology in that 
the vast majority of activities have a therapeutic component and are 
often applied to elderly, critically ill patients; the stochastic risk is 
limited here but the deterministic risk increases. This turns the 
priority of education towards optimisation. Interventional radiologists, 
consecutively, undergo the usual education and training of radiologists 
before they deepen their knowledge (K), skills (S) and competences 
(C) in these aspects during the period of subspecialisation. 
Radiation protection is life-long learning and therefore an integral 
part of continuous professional development. 
 
SP-0127   
ACCIRAD: Organisation and tasks of the European project on 
accidental exposure and risk analysis 
J. Malicki1, H. Jarvinen2, R. Bly3, J.L. Godet4, M. Valero4, A. Jahnen5, 
K. Przybylska6, C. Prieto Martin7, M. Krengli8, P.H. Maingon9 
1Greater Poland Cancer Centre University of Medical Sciences, 
Medical Physics Electroradiology, Poznan, Poland  
2Radiation and Nuclear Safety Authority, Radiation Practices 
Regulation, Helsinki, Finland  
3Radiation and Nuclear Safety Authority, Helsinki, Finland  
4Nuclear Safety Authority, Paris, France  
5Public Research Centre Henri Tudor, Luxembourg, Luxembourg  
6Greater Poland Cancer Centre, Department of Trainings Scientific 
Cooperation and Quality Assurance, Poland, Poland  
7Fundacion Investigacion Biomedica Hospital Clinico San Carlos, 
Madrid, Spain  
8ESTRO, Novarra, Italy  
9ESTRO, Dijon, France  
 
The  ACCIRAD Project is run by the Consortium of the following 
partners Radiation and Nuclear Safety Authority, (Helsinki), Public 
Research Centre Henri Tudor (Luxemburg),  Nuclear Safety Authority 
(Paris); ESTRO; Fundacion Investigacion Biomedica Hospital Clinico San 
Carlos (Madrid) and coordinated by  the Greater Poland Cancer Centre 
from Poznan.  A Panel of 11 Scientific Experts was set up for the 
assessment of the work plans and the results achieved and for the 
support of specified tasks. 
Aim: The main objective is to perform an EU-wide study on the 
implementation of the MED requirements aimed at the reduction of 
the probability and the magnitude of accidents in radiotherapy and to 
develop guidelines on a risk analysis of accidental an unintended 
exposures in external beam radiotherapy. 
Methodology: There are 6 work packages: Management and 
coordination; Questionnaires on MED implementation; Risk analysis of 
accidental and unintended exposures; Classification, reporting, and 
registration of events; European Guidelines; European Workshop. The 
project works are prepared by partners and discussed during six 
meetings and three video conferences. 
The lead contractor is responsible for the management and 
coordination of the project and has ensured the organisation and 
resources needed to fulfill the objectives of the contract. The 
questionnaire was sent out to establish the overall status and the legal 
and practical arrangements in EU Member States. The questionnaire 
was carried out in two steps: general and detailed. The methods or 
risk analyses are being reviewed, partly by an expert knowledge of the 
consortium, partly based on the results of the questionnaire. The 
European Guidelines will be a document on a risk analysis of 
accidental and unintended exposures in external beam radiotherapy 
and will provide comprehensive description of best practices to 
conduct a study of risk of accidental or unintended exposures. The 
proactive methods to identify vulnerable aspects of the radiotherapy 
treatment, using risk matrix or probabilistic safety assessment will 
also be presented in detail. The European Guidelines will be discussed 
during the European Workshop where the feedback from the invited 
expert organisations is awaited.  
Conclusions: More than half of the EU Countries have already 
implemented a requirement for risk analysis in radiotherapy, and 
classification recording, and reporting of adverse events and near 
misses in their legal systems. However, the requirement for legal 
framework for risk analysis, classification of events, recording and 
reporting systems has not been addressed in many EU countries, and 
thus, the practical implementation of the systems in many countries is 
still incomplete. 
Acknowledgement: The following persons are also involved in the 
project: Herbst R., Bulot M., Bogusz-Czerniewicz M., Skrobala A. 
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The European Council Directive 97/43/EURATOM introduce specific 
requirements aimed at the reduction of the probability and the 
magnitude of accidents in radiotherapy. Within a European 
Commission (EC) project, the implementation of these requirements 
in radiotherapy in Europe is reviewed through detailed web-based 
questionnaires, focusing on the national systems of risk management 
in external beam radiotherapy and the national systems for 
classification, recording and reporting of adverse events or near 
misses concerning patient safety in external beam radiotherapy. The 
results, together with a review of available international systems 
related to risk management, are used to prepare European guidelines 
on a risk analysis of accidental and unintended exposures in external 
beam radiotherapy.  
The results of the questionnaires reveals that more than half of the 
countries already implemented the legal basis for risk analysis and 
event’s classification, recording and reporting. However, the lack of 
this basis in many countries and the lack of practical implementation 
in most of the countries highlight the need for further European 
guidelines.   
The guidelines under preparation will review the available risk 
assessment methodologies, both general methodologies like Event 
Tree, Fault Tree and Process analysis including critical point, and 
methodologies dedicated to radiotherapy such as Failure Mode and 
Effects Analysis (FMEA) and Risk Matrix. The risk assessment 
methodologies vary as for their purpose and capabilities in different 
steps of the risk management: hazard and failure identification, 
events’ consequence, likelihood and severity evaluation, actions 
decision process and feedback analysis. The guidelines will discuss the 
value of the various methodologies and give advice and examples on 
their application in radiotherapy, aiming to establish a minimum 
approach dedicated to radiotherapy.  
Further, basic terminology for classification and reporting of adverse 
events and near misses is proposed. Common terminology facilitates 
the analysis and comparison of reported data from different sources 
and is a key to compare the risk of radiotherapy with other health 
care areas. Existing general healthcare taxonomies with specific codes 
for radiotherapy should be used as much as possible in order to 
integrate radiotherapy reporting in existing general healthcare 
reporting systems with an important save of resources.  The event 
reporting systems should preferably be called event learning systems, 
to emphasize that reporting is only one step in a process aimed at 
learning from events.  Departmental reporting/learning systems 
should be part of the safety culture and ideally, a module in 
radiotherapy information systems.  Monitoring is fundamental to 
demonstrate the implementation of remedial actions, to close the 
cycle of learning and improving safety after an event takes place.  
The risk management envisaged in the guidelines will significantly 
contribute to the improvement of patient safety in radiotherapy.  
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Purpose/Objective: Prostate cancer is predominantly a multifocal 
disease, which consists of an index lesion and one or more satellites. 
The success of focal radiation treatment relies primarily on how well 
prostate tumors can be delineated by using MR imaging. The 
sensitivity and specificity for tumor detection on multi-parametric MRI 
is highly reduced for tumors smaller than 5 mm in diameter.  
Focal therapy for prostate cancer can be delivered in different ways. 
Focal-only therapy will treat only the visible tumor and not the whole 
prostate. Focal boost therapy (e.g. FLAME study) will treat the whole 
prostate and boost visible tumor. The aim of this study was to analyze 
distances and volumes of satellites relative to the index lesion in 
order to investigate the potential of a CTV margin for use in focal 
therapy. 
Materials and Methods: A total of 61 patients who underwent a 
radical prostatectomy were included in this study. On the H&E stained 
slides retrieved from these specimens, the uro-pathologist contoured 
the index lesion and satellites. Then the slides were digitized and 
stacked with a 4 mm distance. The slide-stacks were imported in our 
in-house developed delineation program (WorldMatch) for further 
analysis. The distance between the borders of the delineated tumors 
was measured and volumes of all delineated tumors were calculated.  
Results: Of the 61 patients, 51 (84%) had multifocal disease. The 
median number of satellites in all patients was 3. In 50% of the 
patients, the distance of the index lesion to the satellites was 1.0 cm 
or more, with a maximum of 4.4 cm. 
32% of the satellites were smaller than 5 mm in diameter. Of the total 
tumor volume 14% was located in the satellites. However, the 
contribution of satellites smaller than 5 mm to the total tumor volume 
only amounted to an average of 0.9%. 
If all tumors larger than 5 mm were assumed to be GTV, 54% of the 
patients did not have any tumor volume outside of the GTV. 
  
Conclusions: A CTV margin around the index lesion which contains all 
satellites will cover in the majority of patients nearly the entire 
prostate. The limited contribution of satellites smaller than 5 mm to 
the overall tumor load however raises the question as to their clinical 
relevance. If the small satellites are of no/little clinical relevance and 
the GTV for focal therapy includes all tumors ≥ 5 mm in diameter, 
than focal-only therapy to the GTV may be safe. If however small 
satellites are clinically relevant, treatment of the entire prostate is 
necessary with possibly a focal boost to the GTV. 
In both cases, careful screening to identify larger satellites is 
warranted. 
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Purpose/Objective: To compare the 3-dimensional intra-fraction 
variations of prostate position within the pelvis with whole-pelvic 
fixed-field intensity-modulated radiation therapy (IMRT) vs. intensity-
modulated arc therapy (IMAT) in high-risk prostate cancer (PCa). 
Materials and Methods: Fifteen PCa patients underwent whole pelvic 
radiotherapy using either dynamic IMRT with a sliding window 
technique (n= 8) or IMAT (n= 7). All the patients had a kV cone-beam 
computed tomography (CBCT) before and immediately after each 
fraction of IMRT or IMAT. 
Intra-fraction motions of the prostate were determined using a 2-step 
procedure performed on each pre- and post-treatment imaging: 1) 
